•
Jun 30, 2020
Chemours Q2 2020 Earnings Report
Chemours' Q2 2020 results reflect disciplined execution of cash generation strategy amidst COVID-19 impact.
Key Takeaways
Chemours reported net sales of $1.1 billion and net income of $24 million, with an EPS of $0.15. Adjusted EPS was $0.18. The company's free cash flow was $50 million, a $167 million improvement from the prior year. The results were impacted by lower volumes across all segments due to COVID-19.
Net Sales of $1.1 billion.
Net Income of $24 million, with EPS of $0.15.
Adjusted Net Income of $30 million, with Adjusted EPS of $0.18.
Free Cash Flow of $50 million, a $167 million improvement from prior year.
Chemours
Chemours
Chemours Revenue by Segment
Forward Guidance
The outlook for the second half, while improving, remains unclear. Chemours remains focused on the execution of their short-term response plan and long-term strategy.
Positive Outlook
- Focus on short-term response plan.
- Focus on long-term strategy.
- Commitment to customer partnership.
- Aim to deliver full potential of value proposition.
- Prioritizing customer success.
Challenges Ahead
- Unclear outlook for the second half of 2020.
- Navigating uncertain times.
- Dependence on market conditions.
- Potential impact of COVID-19.
- Global economic uncertainty.